Tyrosine kinase inhibitors (TKIs) for ovarian cancer treatment: from organic to inorganic chemotherapeutics towards selectivity-a perspective overview.
Biometals
; 37(2): 275-288, 2024 Apr.
Article
in En
| MEDLINE
| ID: mdl-37930483
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Antineoplastic Agents
Limits:
Female
/
Humans
Language:
En
Journal:
Biometals
Journal subject:
BIOQUIMICA
Year:
2024
Document type:
Article
Affiliation country:
Italia